First ever reported cryo-EM visualization of E. coli TGT structure

Researchers have achieved a groundbreaking milestone in bacteriology by capturing the first-ever cryo-electron microscopy (cryo-EM) visualization of the Escherichia coli tRNA-guanine transglycosylase (TGT) structure. Published in the Proceedings of the National Academy of Sciences, the study reveals that the enzyme binds and modifies two tRNAs simultaneously, challenging previous assumptions about how bacterial TGT functions. This discovery could significantly advance efforts to develop targeted therapies against pathogenic bacteria such as Shigella, which causes shigellosis. The TGT enzyme plays a crucial role in modifying tRNA molecules, a process essential for bacterial survival and virulence. In E. coli, TGT helps regulate protein synthesis, enabling the bacteria to thrive and cause infections. Despite its importance, visualizing the atomic structure of E. coli TGT had proven extremely challenging due to the difficulty of crystallizing the protein. As a result, much of what was known about TGT function came from indirect methods, limiting the precision of scientific understanding. A team led by Professor Neal Devaraj at the University of California, San Diego, overcame these limitations using cryo-EM technology. Their work revealed that E. coli TGT can engage with two tRNA molecules at once, a finding that contradicts earlier models suggesting the enzyme interacts with only one tRNA per cycle. The cryo-EM images showed the enzyme’s active sites accommodating two tRNAs, each undergoing modification. This dual-binding capability suggests a more complex mechanism of action than previously thought, potentially opening new avenues for therapeutic intervention. According to the researchers, this insight could aid in designing more effective inhibitors of TGT, particularly for drug-resistant strains of Shigella. Such inhibitors would target the enzyme without affecting human cells, making them promising candidates for antivirulence drugs. Moreover, the findings may enhance RNA chemical biology applications, allowing scientists to create custom RNA substrates that exploit both binding sites within the enzyme. This could lead to more efficient and specific modifications of tRNA, with implications beyond infectious diseases. Devaraj emphasized the significance of the discovery, noting that understanding the enzyme’s capacity to bind multiple tRNAs offers a novel approach to drug development. “Now that we understand the enzyme can bind two tRNAs at once, we can design an RNA that takes advantage of that, binding several times more tightly than the RNAs we’ve used before,” he explained. This breakthrough underscores the potential of cryo-EM in revealing intricate biological mechanisms that were previously inaccessible through traditional techniques. The study, authored by Alexander Harjung and colleagues, marks a pivotal moment in the field of structural biology. It highlights the power of advanced imaging technologies in uncovering the molecular architecture of enzymes critical to microbial physiology. As further research builds on these findings, the implications for antibiotic resistance and RNA-based therapeutics could become increasingly profound.